Minneapolis, MN, United States of America

Walker Lahr

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Walker Lahr: Innovator in Gene Editing Technology

Introduction

Walker Lahr is a prominent inventor based in Minneapolis, MN. He has made significant contributions to the field of gene editing, particularly through his innovative work at the University of Minnesota. His research focuses on advancing techniques that can potentially revolutionize immunotherapy.

Latest Patents

Walker Lahr holds a patent for "Lymphohematopoietic engineering using CAS9 base editors." This patent outlines methods and systems for targeted gene disruption and targeted gene knock-in in mammalian cells. The technology utilizes base editors and guide RNAs designed to target splice acceptor-splice donor sites. Additionally, the patent describes genetically engineered cells with targeted disruptions in immunotherapy-related genes, which include a CAR/TCR for therapeutic applications. He has 1 patent to his name.

Career Highlights

Lahr's career at the University of Minnesota has been marked by his dedication to advancing gene editing technologies. His work has the potential to impact various therapeutic applications, particularly in the field of immunotherapy.

Collaborations

Walker collaborates with notable colleagues, including Branden Moriarity and Beau R Webber. Their combined expertise enhances the research and development of innovative gene editing solutions.

Conclusion

Walker Lahr is a key figure in the field of gene editing, with a focus on developing advanced techniques for immunotherapy. His contributions through his patent and collaborations position him as an influential inventor in this rapidly evolving area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…